TV

Tejeswini Vasant Kotwal

Active Director Director DIN 08231207
DIN 08231207 First appointment Sep 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Tejeswini Vasant Kotwal

Data last updated:

Tejeswini Vasant Kotwal is a Director at Rushi Critical Care Centre And Multispeciality Hospital Private Limited (since 2018). The company operates in Healthcare.

DIN 08231207
Primary Designation Director
Industry Healthcare
First Appointment 20 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Sep 20182018Active

Board colleagues of Tejeswini Vasant Kotwal

Directorship timeline

Open interactive timeline →
Rushi Critical Care Centre And Multispeciality Hospital Private Limited
Premium access

Shareholding and investment profile for Tejeswini Vasant Kotwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tejeswini Vasant Kotwal

Tejeswini Vasant Kotwal currently holds 1 directorship: Rushi Critical Care Centre And Multispeciality Hospital Private Limited (Director, since 20 Sep 2018).

Tejeswini Vasant Kotwal was first appointed on 20 Sep 2018 as Director at Rushi Critical Care Centre And Multispeciality Hospital Private Limited.

The current boards of Tejeswini Vasant Kotwal's companies include Sharda Vasant Badgujar (Rushi Critical Care Centre And Multispeciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available